Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Posted by Stacy Sanders on Feb 21st, 2025

Eden Research plc (LON:EDEN – Get Free Report) fell 3.3% during mid-day trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm’s fifty day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insiders Place Their Bets

In related news, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek acquired 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.